Repurposing antipsychotic drugs for cancer treatment: current evidence and future perspectives
- 15 October 2021
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 22 (2) , 131-134
Abstract
Today cancer is, undoubtedly, a major health concern. Cancer research is now at a critical crossroad. New data and fresh concepts are transforming traditional views on biology, tumorigenesis, and t...Keywords
Funding Information
- No funding
This publication has 18 references indexed in Scilit:
- Antipsychotic use is inversely associated with gastric cancer risk: A nationwide population‐based nested case‐control studyCancer Medicine, 2019
- A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemiaBlood Advances, 2018
- Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastomaCritical Reviews in Oncology/Hematology, 2018
- Association of Schizophrenia With the Risk of Breast Cancer IncidenceJAMA Psychiatry, 2018
- Repurposing psychiatric drugs as anti-cancer agentsCancer Letters, 2018
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 Genes Involved in the Double-Strand Break Repair Pathway Predict Glioblastoma SurvivalJournal of Clinical Oncology, 2010
- Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969–1993Schizophrenia Research, 2005
- Cancer in schizophrenia: is the risk higher or lower?Schizophrenia Research, 2005
- The incidence of cancer in schizophrenic patients.Journal of Epidemiology and Community Health, 1989